Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.

gan Lipponen, P., Eskelinen, M.
Cyhoeddwyd 1994

Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.

gan Lipponen, P. K., Eskelinen, M. J.
Cyhoeddwyd 1992

Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.

gan Lipponen, P., Eskelinen, M., Syrjänen, K.
Cyhoeddwyd 1995

Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.

gan Lipponen, P. K., Eskelinen, M. J., Nordling, S.
Cyhoeddwyd 1991

The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells

gan Mäkinen, K, Loimas, S, Nuutinen, P, Eskelinen, M, Alhava, E
Cyhoeddwyd 2000

α-Catenin expression has prognostic value in local and locally advanced prostate cancer

gan Aaltomaa, S, Lipponen, P, Ala-Opas, M, Eskelinen, M, Kosma, V-M
Cyhoeddwyd 1999

Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.

gan Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Cyhoeddwyd 1993

A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the di...

gan Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Cyhoeddwyd 1994

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.

gan Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E.
Cyhoeddwyd 1992

Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

gan Aaltomaa, S, Lipponen, P, Ala-Opas, M, Eskelinen, M, Syrjänen, K, Kosma, V-M
Cyhoeddwyd 1999

Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation

gan Ropponen, K, Kellokoski, J, Pirinen, R, Moisio, K, Eskelinen, M, Alhava, E, Kosma, V
Cyhoeddwyd 2001

Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma.

gan Ropponen, K M, Eskelinen, M J, Lipponen, P K, Alhava, E M, Kosma, V M
Cyhoeddwyd 1999

Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.

gan Karjalainen, J. M., Eskelinen, M. J., Nordling, S., Lipponen, P. K., Alhava, E. M., Kosma, V. M.
Cyhoeddwyd 1998

Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women

gan Romppanen, J, Keskikuru, R, Kataja, V, Eskelinen, M, Kosma, V-M, Savolainen, K, Uusitupa, M, Mononen, I
Cyhoeddwyd 1999

p21(WAF1) expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis

gan Pellikainen, M J, Pekola, T T, Ropponen, K M, Kataja, V V, Kellokoski, J K, Eskelinen, M J, Kosma, V-M
Cyhoeddwyd 2003

Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.

gan Setälä, L. P., Kosma, V. M., Marin, S., Lipponen, P. K., Eskelinen, M. J., Syrjänen, K. J., Alhava, E. M.
Cyhoeddwyd 1996

p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis

gan Ropponen, K M, Kellokoski, J K, Lipponen, P K, Pietiläinen, T, Eskelinen, M J, Alhava, E M, Kosma, V-M
Cyhoeddwyd 1999

Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate

gan Setälä, L P, Tammi, M I, Tammi, R H, Eskelinen, M J, Lipponen, P K, Ågren, U M, Parkkinen, J, Alhava, E M, Kosma, V-M
Cyhoeddwyd 1999

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 α in cutaneous melanoma

gan Karjalainen, J M, Kellokoski, J K, Mannermaa, A J, Kujala, H E, Moisio, K I, Mitchell, P J, Eskelinen, M J, Alhava, E M, Kosma, V M
Cyhoeddwyd 2000